stay updated with our newsletter

The Bone-Loss Problem in the GLP-1 Era

In the GLP-1 era, practitioners are helping patients lose weight faster and in larger amounts than before. That makes skeletal protection increasingly important. This article examines five signals that change during weight loss—mechanical loading, estrogen, calcium balance, gut delivery, and rate—and translates them into practical considerations for screening and intervention.

Nicotinamide for Non-Melanoma Skin Cancer Prevention: What the Evidence Shows

Its proposed role in enhancing cellular DNA repair and supporting the skin’s response to ultraviolet-induced damage has prompted investigation into whether supplementation may reduce skin cancer incidence in individuals at elevated risk. Current evidence suggests that nicotinamide may represent a safe, accessible, and relatively inexpensive strategy for skin cancer prevention in predisposed populations.

Galectin-3 and Apheresis: The Future of Medicine

In this webinar, Dr. Eliaz presents groundbreaking research findings and practice-tested protocols to effectively manage Galectin-3, including the use of selective apheresis showing breakthrough results against life-threatening sepsis and other pro-inflammatory conditions. He will also discuss benefits, risks, and common misconceptions related to apheresis.

60-Day Mind|Set Challenge Shows Anxiety Improvements

In a small paired-cohort evaluation, 10 participants completed validated measures of anxiety, perceived stress, and everyday cognitive failures before and after 60 days of daily supplementation. All three measures improved at the group level, although the uncontrolled design and reliance on self-reported outcomes limit conclusions about causation.